Launch of a Strategic Research Agenda on Neuro degenerative diseases
The European Commissions's Joint Programme on Neurodegenerative Diseases (JPND) aims to enhance the impact of research by aligning and building upon existing national programmes and identifying common goals that would benefit from joint action.
One of the first steps towards realising the aims of JPND was the creation of a Strategic Research Agenda (SRA) to provide a framework for future investment and address how the European research effort can most effectively be harnessed to improve prevention, diagnosis, treatment and patient care for neurodegenerative diseases.
The JPND Research Strategy, which forms the basis of the SRA, was released and published on February 7th, 2012.
The JPND strategy represents a vision, endorsed by 24 countries, to coordinate research in neurodegenerative disease, in particular Alzheimer’s across Europe. It addresses the full spectrum of research activity that is required to tackle the growing burden of these diseases for the next decade and beyond.